NASDAQ:KLDO

Kaleido Biosciences Stock Insider Trading

etoro logo Buy KLDO
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jun 03, 2026

Kaleido Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 7.33M and sold 8.27K KLDO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 7.33M shares
Sell 8.27K shares
96% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 28, 2022
Sell
Restricted Stock Units
F-InKind
Van Hylckama Vlieg Johan
Chief Scientific Officer
Officer 2 087
Value: $3K
Feb 28, 2022
Sell
Restricted Stock Units
F-InKind
Korn Jerald
COO & General Counsel
C-Suite Officer 2 046
Value: $3K
Feb 28, 2022
Sell
Restricted Stock Units
F-InKind
Korn Jerald
COO & General Counsel
C-Suite Officer 2 046
Value: $3K
Feb 28, 2022
Sell
Restricted Stock Units
F-InKind
Van Hylckama Vlieg Johan
Chief Scientific Officer
Officer 2 087
Value: $3K
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Van Hylckama Vlieg Johan
Chief Scientific Officer
Officer 350 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Long Alison S
Chief Medical Officer
Officer 125 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Long Alison S
Chief Medical Officer
Officer 46 800
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Korn Jerald
COO & General Counsel
C-Suite Officer 250 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Korn Jerald
COO & General Counsel
C-Suite Officer 45 240
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Duke William E.
Chief Financial Officer
C-Suite Officer 125 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Duke William E.
Chief Financial Officer
C-Suite Officer 44 990
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Menichella Daniel L
Chief Executive Officer
CEO / President 250 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Menichella Daniel L
Chief Executive Officer
CEO / President 70 200
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Menichella Daniel L
Chief Executive Officer
CEO / President 70 200
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Menichella Daniel L
Chief Executive Officer
CEO / President 250 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Duke William E.
Chief Financial Officer
C-Suite Officer 44 990
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Duke William E.
Chief Financial Officer
C-Suite Officer 125 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Korn Jerald
COO & General Counsel
C-Suite Officer 45 240
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Korn Jerald
COO & General Counsel
C-Suite Officer 250 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Long Alison S
Chief Medical Officer
Officer 46 800
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Long Alison S
Chief Medical Officer
Officer 125 000
Value: $0
Jan 14, 2022
Buy
Restricted Stock Units
A-Award
Van Hylckama Vlieg Johan
Chief Scientific Officer
Officer 350 000
Value: $0
Dec 15, 2021
Buy
Stock Option (Right to Buy)
A-Award
Long Alison S
Chief Medical Officer
Officer 300 000
Value: $924.0K
Dec 15, 2021
Buy
Restricted Stock Units
A-Award
Long Alison S
Chief Medical Officer
Officer 24 350
Value: $0
Dec 15, 2021
Buy
Common Stock
J-Other
Long Alison S
Officer
Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT KALEIDO BIOSCIENCES INC.
Kaleido Biosciences
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disea...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE